All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0252 | Anti-AOC3 (BTT-1023) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | BTT-1023 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1152 | Anti-AOC3 (BTT-1023) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | BTT-1023 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP161 | Anti-AOC3 (1G3) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1G3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP162 | Anti-AOC3 (8C10) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 8C10 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP163 | Anti-AOC3 (3G6) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3G6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP164 | Anti-AOC3 (3F10) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3F10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP166 | Anti-AOC3 (Mo2D103) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | Mo2D10 | Chimeric (mouse/human) | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP167 | Anti-AOC3 (1G3) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1G3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP168 | Anti-AOC3 (8C10) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 8C10 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP169 | Anti-AOC3 (3G6) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3G6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP170 | Anti-AOC3 (3F10) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3F10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP172 | Anti-AOC3 (Mo2D103) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | Mo2D10 | Chimeric (mouse/human) | scFv-41BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION